<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-diagnostics-10-00409">
 <label>30.</label>
 <element-citation publication-type="web">
  <article-title>CanSino Biologicsâ€™ Ad5-nCoV the First COVID-19 Vaccine to Phase II Clinical Trials</article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://www.trialsitenews.com/cansino-biologics-ad5-ncov-the-first-covid-19-vaccine-to-phase-ii-clinical-trials/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.trialsitenews.com/cansino-biologics-ad5-ncov-the-first-covid-19-vaccine-to-phase-ii-clinical-trials/</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-05-12">(accessed on 12 May 2020)</date-in-citation>
 </element-citation>
</ref>
